NCT04295057

Brief Summary

Register for the study of the prevalence and burden of diseases, risk factors and outcomes of hospitalizations in older age groups in the countries of Eurasia.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 3, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 4, 2020

Completed
2.9 years until next milestone

Study Start

First participant enrolled

January 15, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2024

Completed
Last Updated

February 2, 2022

Status Verified

February 1, 2022

Enrollment Period

1.2 years

First QC Date

March 3, 2020

Last Update Submit

February 1, 2022

Conditions

MenAge ProblemTherapeutic Alliance

Keywords

registertherapy

Outcome Measures

Primary Outcomes (6)

  • Incidence

    Incidence of non-infectious diseases

    12 months

  • Non-infectious diseases

    Age-related non-infectious diseases dynamics of the development of the main after 60 years

    12 months

  • Age groups

    The prevalence of various non-infectious diseases in different age groups

    12 months

  • Therapy

    Names, doses and duration of prescribed therapy

    12 months

  • Drugs

    Analysis of prescribed therapy and calculation of losses from improper treatment due to repeated hospitalizations, disability and complications

    12 months

  • Measure criteria

    12000 patients

    12 months

Interventions

Non-interventionOTHER

Non-intervention

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Anonymous men and women in the age group over 60 see a doctor for any reason.

You may qualify if:

  • over 60 years
  • Appointment to a doctor of a therapeutic profile

You may not qualify if:

  • Reluctance of the Patient to participate in the Register;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eurasian Association of Therapists

Moscow, 101000, Russia

Location

MeSH Terms

Conditions

Multiple Endocrine Neoplasia Type 1

Condition Hierarchy (Ancestors)

Multiple Endocrine NeoplasiaEndocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsNeoplasms, Multiple PrimaryNeoplastic Syndromes, HereditaryGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesEndocrine System Diseases

Central Study Contacts

Alexandra Deeva

CONTACT

+79033777940adeeva@euat.ru

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Eurasian Association of Therapists

Study Record Dates

First Submitted

March 3, 2020

First Posted

March 4, 2020

Study Start

January 15, 2023

Primary Completion

March 15, 2024

Study Completion

March 15, 2024

Last Updated

February 2, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations

RU(1)